| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Mar―23 |
Multiscale network analysis identifies potential receptors for
SARS-CoV
-2 and reveals their tissue-specific and age-dependent expression |
Christian V. Forst, Lu Zeng, Qian Wang, Xianxiao Zhou, Sezen Vatansever, Peng Xu, Won-Min Song, Zhidong Tu, Bin Zhang |
| 2 |
[GO] |
2022―Sep―02 |
SARS-CoV
-2 spike protein aggregation is triggered by bacterial lipopolysaccharide |
Jitka Petrlova, Firdaus Samsudin, Peter J. Bond, Artur Schmidtchen |
| 3 |
[GO] |
2022―Aug―28 |
Middle East respiratory syndrome coronavirus
ORF4b
protein inhibits
TLR7
- and
TLR9
-dependent alpha interferon induction |
Yoshinori Kitagawa, Takumi Tsukamoto, Masae Itoh, Bin Gotoh |
| 4 |
[GO] |
2022―Jul―27 |
Expanding the Antiviral Potential of the Mosquito Lipid-transfer Protein
AEG12
Against
SARS-CoV
-2 Using Hydrophobic Antiviral Ligands |
Alexander C.Y. Foo, Bernard A.P. Lafont, Geoffrey A. Mueller |
| 5 |
[GO] |
2022―Apr―18 |
Clinically observed deletions in SARS-CoV-2 Nsp1 affect its stability and ability to inhibit translation |
Pravin Kumar, Erin Schexnaydre, Karim Rafie, Tatsuaki Kurata, Ilya Terenin, Vasili Hauryliuk, Lars-Anders Carlson |
| 6 |
[GO] |
2022―Mar―18 |
SARS-CoV-2 3CL
pro
displays faster self-maturation
in vitro
than SARS-CoV 3CL
pro
due to faster C-terminal cleavage |
Chih-Jung Kuo, Po-Huang Liang |
| 7 |
[GO] |
2021―Nov―16 |
Two years into COVID-19 - Lessons in SARS-CoV-2 and a perspective from papers in
FEBS Letters |
Urs F. Greber |
| 8 |
[GO] |
2021―Nov―15 |
SARS-CoV-2 nucleocapsid protein interacts with immunoregulators and stress granules and phase separates to form liquid droplets |
Syam Prakash Somasekharan, Martin Gleave |
| 9 |
[GO] |
2021―Nov―10 |
Neurological Pathophysiology of SARS-CoV-2 and Pandemic Potential RNA Viruses: A Comparative Analysis |
Nikhil Chakravarty, Thrisha Senthilnathan, Sophia Paiola, Priya Gyani, Sebastian Castillo Cario, Estrella Urena, Akash Jeysankar, Prakash Jeysankar, Joseph Ignatius Irudayam, Sumathi Natesan Subramanian, Helen Lavretsky, Shantanu Joshi, Gustavo Garcia, Arunachalam Ramaiah, Vaithilingaraja Arumugaswami |
| 10 |
[GO] |
2021―Aug―19 |
Genome-scale metabolic modelling of SARS-CoV-2 in cancer cells reveals an increased shift to glycolytic energy production |
Elisabeth Yaneske, Guido Zampieri, Loris Bertoldi, Giuseppe Benvenuto, Claudio Angione |
| 11 |
[GO] |
2021―Aug―19 |
Interface-based design of the favipiravir-binding site in SARS-CoV-2 RNA-dependent RNA polymerase reveals mutations conferring resistance to chain termination |
Aditya K. Padhi, Jagneshwar Dandapat, Prakash Saudagar, Vladimir N. Uversky, Timir Tripathi |
| 12 |
[GO] |
2021―Aug―10 |
A glycosaminoglycan microarray identifies the binding of SARS-CoV-2 spike protein to chondroitin sulfate E |
Tomoko Watanabe, Ko Takeda, Keiko Hiemori, Toshikazu Minamisawa, Hiroaki Tateno |
| 13 |
[GO] |
2021―Jul―31 |
Single-dose immunisation with a multimerised SARS-CoV-2 receptor binding domain (RBD) induces an enhanced and protective response in mice |
Ralf Salzer, Jordan J. Clark, Marina Vaysburd, Veronica T. Chang, Anna Albecka, Leo Kiss, Parul Sharma, Andres Gonzalez Llamazares, Anja Kipar, Julian A. Hiscox, Andrew Owen, A. Radu Aricescu, James P. Stewart, Leo C. James, Jan Löwe |
| 14 |
[GO] |
2021―May―15 |
A weak COPI binding motif in the cytoplasmic tail of SARS-CoV-2 spike glycoprotein is necessary for its cleavage, glycosylation, and localization |
Benjamin C. Jennings, Stuart Kornfeld, Balraj Doray |
| 15 |
[GO] |
2021―May―09 |
Serum Levels of the IgA Isotype Switch Factor TGF-β1 are Elevated in Patients with COVID-19 |
Er-yi Wang, Hao Chen, Bao-qing Sun, Hui Wang, Hui-Qi Qu, Yichuan Liu, Xi-zhuo Sun, Jingchun Qu, Zhang-fu Fang, Lifeng Tian, Yi-feng Zeng, Shau-Ku Huang, Hakon Hakonarson, Zhi-gang Liu |
| 16 |
[GO] |
2021―Mar―17 |
Molecular Mechanism of the N501Y Mutation for Enhanced Binding between SARS-CoV-2’s Spike Protein and Human ACE2 Receptor |
Binquan Luan, Haoran Wang, Tien Huynh |
| 17 |
[GO] |
2021―Jan―16 |
Dynamics and electrostatics define an allosteric druggable site within the receptor-binding domain of SARS-CoV2 spike protein |
Sayan Bhattacharjee, Rajanya Bhattacharyya, Jayati Sengupta |
| 18 |
[GO] |
2020―Sep―24 |
Basic and applied science at the time of Covid-19 |
Raffaele Porta, Claudia Martini |
| 19 |
[GO] |
2020―Aug―15 |
Transcriptomic analyses suggest that mucopolysaccharidosis patients may be less susceptible to COVID-19 |
Karolina Pierzynowska, Lidia Gaffke, Grzegorz Węgrzyn |
| 20 |
[GO] |
2020―Jun―11 |
Transforming a research institute into a COVID diagnostic centre - scientists step forward to protect public health during the coronavirus pandemic |
Daniela Ruffell |
| 21 |
[GO] |
2020―May―25 |
SARS-CoV-2 spike glycoprotein-binding proteins expressed by upper respiratory tract bacteria may prevent severe viral infection |
Kourosh Honarmand Ebrahimi |
| 22 |
[GO] |
2020―May―07 |
Knowledge-based structural models of SARS-CoV-2 proteins and their complexes with potential drugs |
Atsushi Hijikata, Clara Shionyu-Mitsuyama, Setsu Nakae, Masafumi Shionyu, Motonori Ota, Shigehiko Kanaya, Tsuyoshi Shirai |
| 23 |
[GO] |
2020―Apr―04 |
Coronavirus SARS-CoV-2: filtering fact from fiction in the infodemic |
Daniela Ruffell |
